[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100555968":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":12,"locations":22,"responsibleParty":40,"collaborators":7,"id":42,"slug":43,"hasResults":44,"nctId":45,"briefTitle":46,"officialTitle":47,"acronym":48,"eligibilityCriteria":49,"healthyVolunteers":44,"sex":50,"minAge":51,"maxAge":7,"enrollmentInfo":52,"targetDuration":55,"studyType":56,"phases":7,"briefSummary":57,"conditions":58,"keywords":61,"overallStatus":66,"whyStopped":7,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":75,"locationsCount":76},{"fullName":5,"class":6},"Ciusss de L'Est de l'Île de Montréal","OTHER",null,[9],{"name":10,"affiliation":5,"role":11},"Pascal Laferrière-Langlois","PRINCIPAL_INVESTIGATOR",[13,17],{"name":10,"role":14,"phone":15,"phoneExt":7,"email":16},"CONTACT","+1-819-432-5847","pascal.laferriere-langlois@umontreal.ca",{"name":18,"role":14,"phone":19,"phoneExt":20,"email":21},"Nadia Godin","514-252-3400","3193","ngodin.hmr@ssss.gouv.qc.ca",[23],{"facility":24,"status":7,"city":25,"state":26,"zip":27,"country":28,"countryCode":29,"cosmosGeoPoint":30,"geoPoint":35,"contacts":36},"Maisonneuve-Rosemont Hospital - CIUSSS de l'Est de l'Île de Montréal","Montreal East","Quebec","H1T2M4","Canada","CA",{"type":31,"coordinates":32},"Point",[33,34],-73.5075,45.63202,{"lat":34,"lon":33},[37,39],{"name":38,"role":14,"phone":15,"phoneExt":7,"email":16},"Pascal Laferrière-Langlois, MD, FRQS",{"name":38,"role":11,"phone":7,"phoneExt":7,"email":7},{"type":11,"investigatorFullName":10,"investigatorTitle":41,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"MD, MSc, FRQS, Assistant Professor, Principal Investigator, Anesthesiologist","100555968","prospective-validation-of-intraoperative-blood-pressure-monitors-100555968",false,"NCT06518980","Prospective Validation of Intraoperative Blood Pressure Monitors","Prospective Validation of Intraoperative Blood Pressure Monitors: the Influence of Site and Execution Strategy. The PROMISES Trial","PROMISES","Inclusion Criteria:\n\n* Fully consented, adult patients above 18 years old;\n* Undergoing surgery of duration time expected at least 60 minutes using general anesthesia;\n* Supine positioning during the surgery;\n* Surgery requiring an arterial line;\n* Both arms available for instrumentation during the surgery.\n\nExclusion Criteria:\n\n* Atrial fibrillation, multifocal atrial tachycardia, or any other irregular hear rythm;\n* Gradient of mean arterial pressure between the two arms greater than 5 mm Hg, as measured during the recruitment process.","ALL","18 Years",{"count":53,"type":54},60,"ESTIMATED","1 Day","OBSERVATIONAL","This observational study aims to identify the incidence and importance of discrepancies between measurements of intraoperative invasive and noninvasive blood pressure monitoring in patients undergoing non-cardiac surgeries under general anesthesia . The main questions it aims to answer are :\n\n* The importance of the differences, in mmHg, between the non-invasive and invasive blood pressure measurements (NIBP-IBP) on systolic, diastolic and mean arterial pressure.\n* Identify the predictive factors associated with these differences.",[59,60],"Anesthesia","Blood Pressure",[62,63,64,65],"anesthesia","blood pressure","noninvasive blood pressure","invasive blood pressure","NOT_YET_RECRUITING","2024-07-19",{"date":69,"type":70},"2024-07-25","ACTUAL",{"date":72,"type":54},"2024-07",{"date":74,"type":54},"2025-10",{"name":5,"class":6},1]